- Home
- AVAV vs VRNA Comparison
AVAV vs VRNA Comparison
Compare AVAV & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVAV
- VRNA
- Stock Information
- Founded
- AVAV 1971
- VRNA 2005
- Country
- AVAV United States
- VRNA United Kingdom
- Employees
- AVAV N/A
- VRNA N/A
- Industry
- AVAV Aerospace
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- AVAV Industrials
- VRNA Health Care
- Exchange
- AVAV Nasdaq
- VRNA Nasdaq
- Market Cap
- AVAV 7.4B
- VRNA 8.3B
- IPO Year
- AVAV 2007
- VRNA 2017
- Fundamental
- Price
- AVAV $265.00
- VRNA $104.67
- Analyst Decision
- AVAV Strong Buy
- VRNA Buy
- Analyst Count
- AVAV 9
- VRNA 11
- Target Price
- AVAV $265.22
- VRNA $114.10
- AVG Volume (30 Days)
- AVAV 2.4M
- VRNA 6.0M
- Earning Date
- AVAV 09-03-2025
- VRNA 08-07-2025
- Dividend Yield
- AVAV N/A
- VRNA N/A
- EPS Growth
- AVAV N/A
- VRNA N/A
- EPS
- AVAV 1.55
- VRNA N/A
- Revenue
- AVAV $820,627,000.00
- VRNA $118,535,000.00
- Revenue This Year
- AVAV $149.20
- VRNA $893.95
- Revenue Next Year
- AVAV $15.45
- VRNA $73.76
- P/E Ratio
- AVAV $171.15
- VRNA N/A
- Revenue Growth
- AVAV 14.50
- VRNA N/A
- 52 Week Low
- AVAV $102.25
- VRNA $18.51
- 52 Week High
- AVAV $295.90
- VRNA $104.99
- Technical
- Relative Strength Index (RSI)
- AVAV 69.13
- VRNA 70.47
- Support Level
- AVAV $228.89
- VRNA $86.63
- Resistance Level
- AVAV $295.90
- VRNA $104.99
- Average True Range (ATR)
- AVAV 15.01
- VRNA 2.54
- MACD
- AVAV -0.04
- VRNA 0.64
- Stochastic Oscillator
- AVAV 71.39
- VRNA 98.26
About AVAV AeroVironment Inc.
AeroVironment Inc operates under a single business segment in which it supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.